Fibrinolytic system proteins in blood and arterial walls [1±6] have been implicated in atherogenesis and in the macroangiopathy typical of non-insulindependent diabetes mellitus (NIDDM). Impairment of fibrinolysis may lead to accumulation of microthrombi that may induce or exacerbate atherogenesis. High concentrations of plasminogen activator inhibitor type-1 (PAI-1) and attenuated fibrinolytic activity are seen in human subjects with obesity, NID-DM, or both [7±10]. Obesity and particularly early stage NIDDM are also characterized by increased concentrations of immunoreactive insulin (IRI) evident in plasma. Several observations suggest a causal connection between hyperinsulinaemia, insulin resistance and impaired fibrinolysis in blood [7±10]. However, the temporal relationships between hyperinsulinaemia, hypertriglyceridaemia, and impaired fibrinolytic system capacity secondary to increased PAI-1 in blood and the onset of macroangiopathy have not yet been elucidated. Accordingly, we studied JCR:LA-cp (corpulent) rats, animals genetically predisposed to develop severe insulin resistance with hyperinsulinaemia, hyperlipidaemia, obesity, and subsequent macroangiopathy [11±14].
normal ( + / + ) rats are lean and indistinguishable from members of the parent LA/N strain. JCR:LAcp cp/cp rats are detectably obese by 3 weeks of age and insulin resistant by 8 weeks of age. In the male cp/cp rat glucose uptake and turnover are no longer responsive to insulin by 12 weeks of age [12] . Marked VLDL hyperlipidaemia is evident and attributable to increased VLDL secretion rather than reduced clearance [13] . The male JCR:LA-cp rat develops atherosclerosis with frank lesions usually beginning after 6 months of age and extensive lesions evident in the aortic arch in 100 % of male cp/cp rats at 9 months of age [14] . A less severe form of atherosclerosis is manifested after 18 months of age in female JCR:LA-cp rats homozygous for the corpulent trait [14] . Thus, the JCR:LA-cp rat provides a unique opportunity to characterize the changes in fibrinolytic activity in blood in temporal relation to changes in concentrations of moieties such as insulin and triglyceride. Because the vasculopathy is predominant in the male animals, male JCR:LA-cp homozygous corpulent (cp/ cp) and homozygous control (+ / +) rats of 1, 2, 4, 6, and 9 months of age were studied. Female homozygous corpulent (cp/cp) and control (+ / +) rats of 6 months of age were studied.
Materials and methods
Animals were handled in accordance with the National Institutes of Health (NIH) guidelines for laboratory animal care (Principles of laboratory animal care, NIH publication No. 85±23) and with protocols approved by the University of Vermont Animal Care and Use Committee. Animals were kept on a 12 h light/dark cycle and fed ad libitum. Samples of blood and tissue were obtained from animals in a fed state. Rats were anaesthetized with intraperitoneal injections of sodium pentobarbital (120 mg/kg body weight). Blood was obtained by cardiac puncture and the aorta was removed under sterile conditions. Blood samples were centrifuged for 20 min at 2000 g at 4°C. Plasma was collected and stored at ±70°C. The numbers of JCR:LA-cp male, cp/cp corpulent and + / + lean rats used in the experiments were: at 1 (n = 3cp, 3 + / + ), 2 (n = 3cp, 3 + / + ), 4 (n = 4cp, 4 + / + ), 6 (n = 7cp, 8 + / + ), and 9 (n = 10cp, 6 + / + ) months of age; where n = number rats in each experimental group. At 6 months of age there were 7 female cp/cp rats and 8 female + / + rats.
Quantification of plasma glucose, insulin, and triglycerides. Plasma glucose was measured by the glucose oxidase method of Trinder [15] with the use of Sigma kit 315 (Sigma Chemical Co., St. Louis, Mo., USA). Insulin was measured with the use of a Coat-A-Count Insulin Kit TKIN1 (Diagnostic Products Corporation, Los Angeles, Calif., USA). In the assay 125 I-labelled insulin competes with insulin in the plasma sample for sites on insulin-specific antibody immobilized to the wall of polypropylene tubes. The antibody-bound fraction was detected with a gamma counter, with the counts being directly proportional to the amount of insulin in the plasma sample. Cross-reactivity with proinsulin is approximately 40 % (per manufacturer's specification). Rat insulin (Crystal Chem, Chicago, Ill., USA) was used to define a standard curve. Plasma triglycerides were measured by a modification of the method of Bucolo and David [16] with the use of Sigma kit 336. In this assay, triglycerides are converted to glycerol and fatty acids. Through a series of reactions involving ATP and NAD, NADH is generated and detected with a chromogenic substrate, 2-(p-iodophenyl)-3-p-nitrophenyl-5-phenyltetrazolium that forms a highly coloured formazan with a maximum absorbance at 500 nm directly proportional to the concentration of triglycerides in the sample.
Organ culture. The aortas excised under sterile conditions were placed in sterile Hank's balanced salt solution (HBSS) containing 300 U/ml penicillin and 300 mg/ml streptomycin. Adherent fat and connective tissue were trimmed and blood cells were washed away with HBSS. The aorta was then cut into ring segments of 1±2 mm widths and cultured in Dulbecco's Modified Eagle's Medium with Ham's nutrient mixture F12 (DME/F12, [Gibco, BRL, Grand Island, N. Y., USA]) supplemented with 1 % bovine serum albumin (BSA, [Sigma]), 50 U/ml penicillin, and 50 mg/ml of streptomycin; incubated at 37°C in an atmosphere of 5 % C0 2 :95 % air. Culture medium was exchanged daily. No evidence of infection was observed by microscopic evaluation of all samples. Conditioned media were screened for endotoxin contamination with the Limulus ameobocyte lysate assay and did not exhibit contamination exceeding 0.01 ng/ml (100-times less than concentrations required to stimulate expression of PAI-1 [17] ).
Quantification of PAI-1 and t-PA. PAI-1 activity in plasma was measured as previously described [18] . Briefly, a fixed amount of t-PA was added in excess to plasma rapidly generating an inactive complex of t-PA with PAI-1 present in the plasma sample. After dilution, the sample was exposed to plasminogen in the presence of cyanogen bromide fragments of fibrinogen. The amount of plasmin generated was determined based on measurement of the amidolytic activity of plasmin on the chromogenic substrate S-2251 (Chromogenix) resulting in the release of p-nitroaniline determined by absorbance at 405 nm. The amount of residual t-PA activity determines the amount of plasmin formed and is inversely proportional to the amount of PAI-1 activity in the sample.
Plasma t-PA activity was measured with an indirect amidolytic method involving the activation of plasminogen in the presence of fragments of fibrinogen based on generation of para-nitroanilide from the plasmin specific substrate S-2251 (Chromogenix) [19] .
PAI-1 protein content of culture medium obtained from aorta ring cultures was assayed by Western blot analysis. PAI-1 was immunoprecipitated from the conditioned medium by overnight incubation at 4°C with a rabbit anti-rat IgG. The antibody/antigen complexes were isolated with protein G sepharose (Pharmacia, Piscataway, N. J., USA). The samples were electrophoresed with SDS-PAGE under non-reducing conditions in order to prevent separation of the IgG into light and heavy chains. After transfer of proteins to Trans-Blot membrane (Bio-Rad, Hercules, Calif., USA), PAI-1 was detected with rabbit anti-rat PAI-1 IgG (American Diagnostica, Greenwich, Conn., USA) and a secondary alkaline phosphatase conjugated antibody mouse anti-rabbit IgG. Gels were scanned with a Logitech Scanman (Logitech, Inc., Fremont, Calif., USA) with the use of a Sigma Gel program (Jandel Corporation, San Rafael, Calif., USA) for calculation of intensity of standard PAI-1 and PAI-1 present in samples. In order to facilitate a semiquantitative analysis of each blot, a fixed amount of a rat PAI-1 standard (American Diagnostica) was electrophoresed on each gel. Thus, the intensity of PAI-1 in a given sample is expressed as a fraction of the intensity of the PAI-1 standard.
Statistical analysis. Student's t-test was used to detect differences between experimental groups for samples having equal variances. The Mann-Whitney Rank Sum Test was used for samples with unequal variances. Spearman's Rank Order Correlation was used for correlation tests.
Results
Plasma glucose, insulin, and triglycerides. Figure 1 shows the concentrations of plasma glucose, insulin and triglycerides in JCR:LA-cp cp/cp corpulent and + / + lean control rats at 1, 2, 4, 6, and 9 months of age. Glucose was elevated in cp/cp rats compared with + / + controls at 2, 4, and 9 months of age. Insulin and triglyceride were markedly elevated at all observation times.
PAI-1 activity in rat plasma. As shown in Figure 2 , PAI-1 activity in plasma of JCR:LA-cp cp/cp corpulent rats was significantly elevated compared with that in + / + lean control rats in animals of 1, 6, and 9 months of age. Although plasma concentrations of t-PA appeared to be increased in both cp/cp corpulent and + / + lean control rats at 2 to 9 months of age, there were no significant differences between cp/cp and + / + rats.
Correlation of PAI-1 with plasma glucose, insulin, and triglycerides. The increased PAI-1 activity in plasma (n = number rats in each experimental group). Data are means ± SEM of plasma concentrations of PAI-1 and t-PA. PAI-1 is expressed in arbitrary units (AU) indicating measurement of PAI-1 remaining after the reaction. t-PA is expressed in international units (IU) and is a direct measure of t-PA concentration detected by the assay. Statistical differences were determined by t-test for samples with equal variances and by Mann-Whitney Rank Sum Test for samples with unequal variances. Statistical tests compared cp/cp rats with + / + rats at each observation interval, * p < 0.05, ** p < 0.01, *** p < 0.001 was significantly correlated with increases in insulin (p < 0.001) and with increases in triglycerides (p < 0.001) (Fig. 3) , whereas PAI-1 activity was not correlated with glucose concentration (data not shown).
Comparison of results in male and female rats of 6 months of age. As shown in Figure 4 , plasma glucose concentrations did not differ among any of the groups. Both male and female cp/cp rats had significantly increased concentrations of insulin in plasma compared with values in + / + control rats, p < 0.001. Insulin values in male cp/cp rat plasma were not different from those in female cp/cp rat plasma, while male + / + rats had slightly higher insulin values compared with + / + females (p < 0.05). Both male and female cp/cp rats showed significantly increased concentrations of triglycerides in plasma (Fig. 4) . The increased plasma triglyceride concentrations in female cp/cp rats (7.12 ± 0.60 mmol/l) were more pronounced than in male cp/cp rats (2.09 ± 0.22 mmol/l). Plasma PAI-1 activity in both male and female cp/cp rats was higher than in corresponding + / + rats (Fig. 5) . There was no difference in PAI-1 activity in male compared with female cp/cp rats, whereas female + / + rats had moderately higher PAI-1 activity compared with male + / + rats (p < 0.02). No differences in t-PA activity were seen.
PAI-1 protein in aorta ring culture medium. Results of Western blot analysis for PAI-1 protein accumulated in 24-h conditioned media from aortic rings in culture from 6-month-old male and female cp/cp and + / + rats are shown in Figure 6 . As can be seen, the elaboration of PAI-1 over 24 h was substantially (4-fold) and significantly (p < 0.001) higher in aortas taken from corpulent males than from lean males and females of both phenotypes. Although the semiquantitative analysis precluded determination of subtle differences, there was a consistent and marked excess of PAI-1 seen in media conditioned by aortas from corpulent males.
Discussion
Fibrinolytic capacity reflects a balance between activity of plasminogen activators in blood (primarily Comparison of glucose, insulin, and triglyceride concentrations in blood obtained from JCR:LA-cp cp/cp corpulent male (n = 7) and female (n = 7) R, and + / + lean male (n = 8) and female (n = 8) rats at 6 months of age. Data are means ± SEM of plasma concentrations of glucose, insulin, and triglycerides. Statistical differences were determined by ttest for samples with equal variances and by Mann-Whitney Rank Sum Test for samples with unequal variances. Statistical significance comparing cp/cp rats with + / + rats; *** p < 0.001, and comparing male cp/cp rats with female cp/cp rats; § p < 0.05, § § p < 0.01 t-PA) and their primary physiologic inhibitor, PAI-1. It is likely to be critical in influencing the thrombotic response to vascular injury and plaque rupture. Decreased fibrinolytic capacity is anticipated to potentiate the persistence of microthrombi. The net effect is likely to be increased arterial mural exposure to thrombi and their associated mitogens that can accelerate atherogenesis by potentiating migration and proliferation of smooth muscle cells as well as deposition of extracellular matrix [20±22] .
Subjects with NIDDM have a high incidence of cardiovascular events [23±25]. Up to 16.6 % of patients will have a cardiovascular event during the first 10 years after diagnosis of diabetes [23] . This high incidence of cardiovascular events early after the diagnosis of diabetes suggests that the insulin resistant state precedes the diagnosis of diabetes by many years and is likely to contribute. Hyperinsulinaemia secondary to end-organ insulin resistance is present 1 to 2 decades before the onset of overt diabetes [26] . We, and others have shown that the concentration and activity of PAI-1 are increased in the blood of subjects with NIDDM and obesity [7±10] .
JCR:LA-cp rats develop insulin resistance and resultant hyperinsulinaemia, hypertriglyceridaemia, and atherosclerosis [11±14], features consistent with NIDDM and its antecedents. Accordingly, we characterized the temporal relationship between the development of abnormalities in metabolism and fibrinolytic capacity in blood in these animals.
Our results show that the activity of PAI-1 is increased in the blood of the cp/cp rats at 1, 6, and 9 months of age. The increased PAI-1 activity was observed in blood from 1-month-old animals homozygous for the corpulent trait. Because previous studies with this animal preparation have indicated that raised intimal lesions are not present (by electron microscopy) in male animals less than 6 months of age [14] , the abnormal expression of PAI-1 precedes the development of vasculopathy. Female rats homozygous for the corpulent gene do not develop significant atherosclerosis until 18 months of age [14] . Thus, increased PAI-1 activity in blood precedes the development of vasculopathy in both sexes. The activity of PAI-1 is increased similarly in the blood of male and female corpulent rats. Despite this, the development of vasculopathy is delayed in females. These results are consistent with the relatively delayed development of atherosclerosis in women with NIDDM [23, 25] and underscore its multifactorial aetiology.
Oestrogen appears to have a protective effect on the development of vasculopathy [27, 28] . The cardiovascular protection has been described as a direct effect on the vessel wall as well as an indirect effect on lipid metabolism [27, 28] . Wagner and colleagues [28] have shown that although combined therapy with oestrogen and progesterone may increase fasting insulin and glucose levels in cynomolgus monkeys, it does not appear to accelerate the progression of vasculopathy. Accordingly the slower progression Comparison of PAI-1 and t-PA activity in blood obtained from JCR:LA-cp cp/cp corpulent male (n = 7) and female (n = 7) R, and + / + lean male (n = 8) and female (n = 8) rats at 6 months of age. Data are means ± SEM of plasma concentrations of PAI-1 and t-PA. Statistical differences were determined by t-test comparing cp/cp rats with + / + rats and male rats with female rats. ** p < 0.01, *** p < 0.001 for cp/cp rats compared with + / + rats, § p < 0.02 for male rats compared with female rats Fig. 6 . PAI-1 protein accumulated in 24 h conditioned media of cultured aorta rings obtained from JCR:LA-cp cp/cp corpulent male (n = 7) and female (n = 8), R and + / + lean male (n = 7), and female (n = 8) A rats at 6 months of age. Western blot shows bands corresponding to graph below and PAI-1 standard (far right). Data are means ± SEM of concentrations of PAI-1 in conditioned media. Statistical differences were determined with the use of the Mann-Whitney Rank Sum Test for comparison of cp/cp rats with + / + rats, *** p < 0.001 of vasculopathy in the female corpulent JCR:LA-cp rat compared with the corpulent male may be related in part to the effects of oestrogen.
As in human subjects [7±10], activity of PAI-1 in blood from JCR:LA-cp rats correlated positively and significantly with concentrations of both insulin and triglycerides in blood. No significant association was observed between the modest elevations in glucose and the increased PAI-1 activity seen in these animals. These results are consistent with our results in vitro demonstrating direct effects of both insulin and triglycerides on expression of PAI-1 and a synergistic augmentation when increased concentrations of both agents are present [29] . Nevertheless, the male and female cp/cp rats exhibited similar elevations of insulin and of PAI-1 activity but triglycerides were significantly increased in female cp/cp compared with male cp/cp. Results in JCR:LA-cp rats are consistent with the hypothesis that hormonal and metabolic abnormalities that precede the development of overt diabetes may potentiate the development of atherosclerosis, in part, by modulating expression of fibrinolytic capacity.
The cellular source of increased PAI-1 in the blood of subjects with obesity and NIDDM has not yet been elucidated. Data from studies in vivo and in vitro suggest that hepatocytes, adipocytes, platelets and vascular wall cellular components can contribute [29±32] . Arterial expression of PAI-1 is increased in rabbits infused with insulin and proinsulin [33] . We have shown that insulin directly augments expression of PAI-1 by human arteries in vitro [34] . Our results with aortas obtained from JCR:LA-cp corpulent rats support the possibility that increased arterial expression of PAI-1 may contribute to the increased PAI-1 in blood from corpulent males. Thus, increased accumulation of PAI-1 was observed in media of cultured aortic rings from cp/cp males even without addition of exogenous insulin. The lack of increased expression of PAI-1 by aortic rings from corpulent females is consistent with decreased vascular elaboration of PAI-1 in direct proportion to the circulating concentration of oestrogen, as reported in the Framingham Offspring Study [35] .
Both the hyperinsulinaemia and hypertriglyceridaemia seen in corpulent atherosclerosis-prone JCR:LA-cp rats of 4 weeks of age or more are paralleled by increased PAI-1 activity in blood. These abnormalities precede the development of atherosclerosis. Further definition of the role of PAI-1 in atherogenesis may delineate potential targets for therapy designed to retard progression of macroangiopathy.
